|
NIPBL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.076400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.954600E-01 |
| Normal-vs-Stage2 |
7.983400E-01 |
| Normal-vs-Stage3 |
8.876400E-01 |
| Normal-vs-Stage4 |
4.585800E-01 |
| Stage1-vs-Stage2 |
9.117400E-01 |
| Stage1-vs-Stage3 |
9.810200E-01 |
| Stage1-vs-Stage4 |
5.678800E-01 |
| Stage2-vs-Stage3 |
9.103200E-01 |
| Stage2-vs-Stage4 |
5.278000E-01 |
| Stage3-vs-Stage4 |
5.787800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.991200E-01 |
| Normal-vs-AfricanAmerican |
6.979400E-01 |
| Normal-vs-Asian |
6.333200E-01 |
| Caucasian-vs-AfricanAmerican |
9.436400E-01 |
| Caucasian-vs-Asian |
8.494800E-01 |
| AfricanAmerican-vs-Asian |
8.483400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.504000E-01 |
| Normal-vs-Female |
6.046400E-02 |
| Male-vs-Female |
3.201700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.293800E-01 |
| Normal-vs-Extreme_Weight |
7.898800E-01 |
| Normal-vs-Obese |
3.637200E-01 |
| Normal-vs-Extreme_Obese |
2.198400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.860800E-01 |
| Normal_Weight-vs-Obese |
3.270000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.690400E-01 |
| Extreme_Weight-vs-Obese |
5.734600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.900600E-01 |
| Obese-vs-Extreme_Obese |
1.559550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.121700E-02 |
| Normal-vs-Age(41-60Yrs) |
9.989900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.791800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.625800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.241400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.143300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.218800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.581600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.154200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.645200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.161600E-01 |
| Normal-VS-Type2 PRCC |
3.600500E-02 |
| Normal-VS-KIRP CIMP |
2.509800E-01 |
| Normal-VS-Unclassified PRCC |
2.225200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.563700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.644360E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.958000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.324600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.164500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.273800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.045500E-02 |
| Normal-vs-N1 |
2.664200E-01 |
| Normal-vs-N2 |
1.476750E-01 |
| N0-vs-N1 |
2.482200E-02 |
| N0-vs-N2 |
6.674800E-01 |
| N1-vs-N2 |
1.314360E-01 |
|
|
